Open Orphan to commence influenza human challenge study by John Pinching | Aug 4, 2022 | News | 0 Candidate exhibits a novel mechanism of action and differs considerably from previously approved drugs Read More
Green light for UK trial of nasal coronavirus vaccine by Selina McKee | Dec 15, 2020 | News | 0 The trial is expected to begin next month, with first data anticipated in the second quarter of 2021 Read More
Open Orphan announces £2.5m influenza challenge study contract by Lucy Parsons | Nov 6, 2020 | News | 0 Company subsidiary hVIVO will conduct study with a US biotech Read More